Evidence map›Paper›PMID 28557543›Full record

ArticleAmerican journal of respiratory and critical care medicine2017

Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages.

Martin A Bewley, Julie A Preston, Mohammed Mohasin, Helen M Marriott, Richard C Budd, Julie Swales, Paul Collini, David R Greaves, Ruth W Craig, Christopher E Brightling and 6 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05743582 (Analysis of Innate Immune Competence in People With Chronic Obstructive Pulmonary Disease), which is not on this map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05743582 recruitingnot on this mapstarted 2023, after this paper: background citation

Analysis of Innate Immune Competence in People With Chronic Obstructive Pulmonary Disease (COPD)

TypeobservationalSponsorUniversity of EdinburghRan2023 to 2028Enrolled189ConditionsChronic Obstructive Pulmonary DiseaseArmsBronchoscopy for sample collection, Blood donation
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Macrophages and the microbiome in chronic obstructive pulmonary disease.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  13. The role and therapeutic potential of itaconate in lung disease.Cellular & molecular biology letters · 2024
    Review
  14. Review
  15. Article
  16. Macrophage Dysfunction in Respiratory Disease.Results and problems in cell differentiation · 2024
    Review
  17. How inhaled corticosteroids target inflammation in COPD.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  18. Does Chronic Obstructive Pulmonary Disease Originate from Different Cell Types?American journal of respiratory cell and molecular biology · 2023
    Article
  19. Article
  20. "KEAP"ing Alveolar Macrophage Mitochondria Content in Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2023
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 3 countries.

Martin A Bewley1 The Florey Institute for Host-Pathogen Interactions and.
Julie A Preston1 The Florey Institute for Host-Pathogen Interactions and.
Mohammed Mohasin1 The Florey Institute for Host-Pathogen Interactions and.
Helen M Marriott1 The Florey Institute for Host-Pathogen Interactions and.
Richard C Budd1 The Florey Institute for Host-Pathogen Interactions and.
Julie Swales1 The Florey Institute for Host-Pathogen Interactions and.
Paul Collini1 The Florey Institute for Host-Pathogen Interactions and.
David R Greaves4 Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
Ruth W Craig5 Department of Pharmacology and Toxicology, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire.
Christopher E Brightling6 Instiute for Lung Heath, University of Leicester, Leicester, United Kingdom.
Louise E Donnelly7 Airway Disease National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Peter J Barnes7 Airway Disease National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Dave Singh8 Centre for Respiratory and Allergy, University of Manchester, Manchester, United Kingdom.
Steven D Shapiro11 Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and.
Moira K B Whyte12 Department of Respiratory Medicine.
David H Dockrell13 MRC Centre for Inflammation Research, and.ORCID 0000-0002-2718-4861
Florey Institute of Neuroscience and Mental Health · AUCentre for Inflammation Research · GBUniversity of London · GBDartmouth College · USUniversity of Leicester · GBUniversity of Manchester · GBUniversity of Oxford · GBUniversity of Pittsburgh Medical Center · US

Funding

British Heart Foundation RG/15/10/31485Medical Research Council G0901963Medical Research Council G1001372Medical Research Council MR/N02995X/1Wellcome TrustWellcome Trust 076945
6 · The paper itself

Abstract

rationaleChronic obstructive pulmonary disease (COPD) is characterized by impaired clearance of pulmonary bacteria.

objectivesThe effect of COPD on alveolar macrophage (AM) microbicidal responses was investigated.

methodsAMs were obtained from bronchoalveolar lavage from healthy donors or patients with COPD and challenged with opsonized serotype 14 Streptococcus pneumoniae. Cells were assessed for apoptosis, bactericidal activity, and mitochondrial reactive oxygen species (mROS) production. A transgenic mouse line in which the CD68 promoter ensures macrophage-specific expression of human induced myeloid leukemia cell differentiation protein Mcl-1 (CD68.hMcl-1) was used to model the molecular aspects of COPD. MEASUREMENTS AND MAIN

resultsCOPD AMs had elevated levels of Mcl-1, an antiapoptotic B-cell lymphoma 2 family member, with selective reduction of delayed intracellular bacterial killing. CD68.hMcl-1 AMs phenocopied the microbicidal defect because transgenic mice demonstrated impaired clearance of pulmonary bacteria and increased neutrophilic inflammation. Murine bone marrow-derived macrophages and human monocyte-derived macrophages generated mROS in response to pneumococci, which colocalized with bacteria and phagolysosomes to enhance bacterial killing. The Mcl-1 transgene increased oxygen consumption rates and mROS expression in mock-infected bone marrow-derived macrophages but reduced caspase-dependent mROS production after pneumococcal challenge. COPD AMs also increased basal mROS expression, but they failed to increase production after pneumococcal challenge, in keeping with reduced intracellular bacterial killing. The defect in COPD AM intracellular killing was associated with a reduced ratio of mROS/superoxide dismutase 2.

conclusionsUp-regulation of Mcl-1 and chronic adaption to oxidative stress alter mitochondrial metabolism and microbicidal function, reducing the delayed phase of intracellular bacterial clearance in COPD.

Indexed as

AnimalsAnti-Infective AgentsBlotting, WesternBronchoalveolar LavageDisease Models, AnimalFlow CytometryHumansMacrophages, AlveolarMiceMice, TransgenicMitochondriaOxidative StressPulmonary Disease, Chronic ObstructiveAnti-Infective Agentsapoptosismitochondrial reactive oxygen speciesStreptococcus pneumoniae

Identifiers

PMID28557543
PMCPMC5649972
OpenAlexW2617197254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.